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Introduction
There are contradictory guidelines by medical organizations on screening for prostate cancer. The recommendation for prostate cancer screening by the American Urological Association and the American Cancer Society is for all men aged 50 years and above with life expectancy >10 years and starting at age 40-45 years for high-risked men (eg African Americans and those with affected first degree relatives) [1, 2] . However, the National cancer Institute [3] and the United States Preventive Service Task Force [4] do not recommend screening for prostate cancer in the general population or high risk individuals.
The objective of prostate cancer screening is to decrease morbidity or mortality from the disease. However, there is currently no conclusively acceptable evidence to establish whether screening for prostate cancer actually achieves this objective. Prostate cancer screening may reduce mortality from the disease almost by half but with a substantial risk of overdiagnosis [5] . The European Randomized Study of Screening for Prostate Cancer (ERSPC) also demonstrated that population-based screening of men aged 55-75 years can reduce prostate cancer mortality [6, 7] . Although population-based screening has not been embraced at the moment, individual patient testing or annual PSA testing is supported. There is therefore no doubt that men should be given individual opportunities take informed decisions whether or not to undertake prostate cancer screening.
Prostate cancer is a leading cancer diagnosis and cause of cancerrelated deaths among men. It is the most commonly diagnosed cancer among Nigerian men [8, 9] . An estimated hospital prevalence of 127 per 100,000 in Lagos, Nigeria was reported in 1997 [10] . A recently published data from southwestern Nigeria also reported a hospital prevalence rate of 182.5 per 100,000 male admission in the hospital [11] .However, the true prevalence in the Nigerian community is not known. In the United States, prostate cancer has been described to be more prevalent among the African-Americans.
The incidence of prostate cancer among White American men is 156.7 per 100,000 population compared with 248.5 for Black Americans [12] . However, the incidence among the black African community may be underestimated [13, 14] . In this study, we aim to describe the prevalence and the characteristics of prostate cancer among the participants of a community-based prostate cancer awareness program that took place in Lagos, Nigeria with a view to throw more lights into the status of the disease in the community. LGA. The mean and median ages were 60.8 and 60 years respectively. Data for serum PSA and DRE was unavailable for 13 (0.3%) and 25 (0.6%) men who refused either of the procedures respectively. In addition, 24 (0.6%) men who were already on medical treatment or urinary catheter for lower urinary tract symptoms (LUTS) were excluded. Therefore 4110 (98.5%) men were included in the final analysis. Table 1 summarizes the data from the men who participated in the program.
Methods
The serum PSA values ranged from 0 to 438.3ng/ml with median value of 1.5ng/ml and mean of 2.5ng/ml. The 95 th percentile PSA value was 10ng/ml. PSA values ≤4.0ng/ml were seen 3398 (82%)
men, values >4.0 to ≤10 ng/ml were seen in 414 (10%) men, values >10ng/ml to ≤20ng/ml were seen in 194 (5%) men and values >20ng/ml were seen 104 (3%) men. There was a significant correlation between the serum total PSA and the age of the men (p<0.001). Categorizing the age as 40-49, 50-59, 60-69 and ≥70
years, the median (and the 95th percentile) PSA were 0.8 (4.5), 1.3 (6.0), 1.6 (10.1) and 1.9 (13.4) ng/ml respectively ( Table 1) .
There were 410(10%) men who had abnormal DRE and the distribution according to the age group is shown in 
Discussion
Prostate cancer screening is not a common practice in Nigeria in spite of prostate cancer being the most commonly diagnosed cancer in Nigerian men [8] . Awareness about prostate cancer is also poor [15, 16] . Majority of our patients therefore usually present in the hospital with the disease in the advanced stage [11] . This community-based testing for prostate cancer which was entirely at no financial cost for the participants has given the opportunity to create more awareness about the disease in the community. It also helped to show the status of the disease in the community better than a hospital-based study.
The estimated prevalence of prostate cancer in this cohort was at least 1046 per 100,000 men of age 40 years and above. This value is much greater than that previously reported in a hospital-based study in Lagos [10] and appears similar to a report from Saudi
Arabia [17] . The prevalence rate is expected to be higher than what has been obtained considering that only 78% of men in whom biopsy was indicated actually had biopsy performed and that biopsy
was not performed on all men with PSA >4ng/dl. Although the men in this study are community-dwelling, it may be possible that men who have worries about their health are more likely to present.
What is of more concern however is the number of supposedly 
Conclusion
This study has demonstrated that there is a high prevalence of prostate cancer in the community in Lagos, much higher than the previously known. The majority of the men already have advanced and high grade disease and have not even sought for medical treatment. (7) 169 (12) 101 (14) 410 (10) Referred for biopsy N (%) 3 (2) 145 (8) 180 (13) 110 (15) 
